Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Jeff Evans
Thomas Jeff Evans
Beatson West of Scotland Cancer Centre
Medicine
Pathology
Amyloid precursor protein secretase
Cancer
Notch signaling pathway
3
Papers
30
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.
2018
Journal of Clinical Oncology
Irina Redchenko
Federica Cappuccini
Emily Pollock
Richard J. Bryant
Lucy Carter
Clare Verrill
Julianne Hollidge
Louise Goodwin
Richard Harrop
Pedro Romero
Selena Vigano
Thomas Jeff Evans
James Catto
Freddie C. Hamdy
Adrian V. S. Hill
Show All
Source
Cite
Save
Citations (3)
Safety, pharmacokinetics and efficacy of IMCgp100, a first-in-class soluble TCR-antiCD3 bispecific t cell redirector with solid tumour activity: Results from the FIH study in melanoma.
2016
Journal of Clinical Oncology
Mark R. Middleton
Neil Steven
Thomas Jeff Evans
Jeffrey R. Infante
Mario Sznol
Clive Mulatero
Omid Hamid
Alexander N. Shoushtari
William Shingler
Andrew Johnson
Sanjay Patel
Debbie Parker
David Krige
Cheryl McAlpine
Christina M. Coughlin
Namir J. Hassan
Bent K. Jakobsen
Philippa Corrie
Show All
Source
Cite
Save
Citations (19)
A phase I trial of the ɣ-secretase inhibitor (GSI) MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma (PDAC).
2014
Journal of Clinical Oncology
Natalie Cook
Bristi Basu
Donna-Michelle Smith
Aarthi Gopinathan
Thomas Jeff Evans
William P. Steward
Thorsten Hagemann
Balaji Venugopal
David A. Tuveson
Mirela Hategan
David Alan Anthoney
Hayley Farmer
Helen Turner
Robert Mcleod
Sarah Halford
Duncan I. Jodrell
Show All
Source
Cite
Save
Citations (8)
1